WealthTrust Fairport’s Teva Pharmaceuticals TEVA Stock Holding History

WealthTrust Fairport’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$0	Hold	28	–	–	﹤0.01%	464
2018 Q4	$0	Hold	28	–	–	﹤0.01%	511
2018 Q3	$1K	Hold	28	–	–	﹤0.01%	497
2018 Q2	$1K	Hold	28	–	–	﹤0.01%	489
2018 Q1	$0	Buy	+28	New	+$547	﹤0.01%	516
2015 Q1	–	Sell	-28	Closed	-$2K	–	351
2014 Q4	$2K	Hold	28	–	–	﹤0.01%	421
2014 Q3	$2K	Hold	28	–	–	﹤0.01%	326
2014 Q2	$1K	Hold	28	–	–	﹤0.01%	340
2014 Q1	$1K	Buy	+28	New	+$1.29K	﹤0.01%	286
2013 Q4	–	Sell	-53	Closed	-$2K	–	404
2013 Q3	$2K	Buy	+53	New	+$2.07K	﹤0.01%	395

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WealthTrust Fairport's TEVA Position: Q1 2019 in Review

WealthTrust Fairport held its Teva Pharmaceuticals (TEVA) position steady in Q1 2019 at 28 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #464.

WealthTrust Fairport first reported a position in TEVA in Q3 2013 and has held it in 10 quarters since. The position peaked at $2K in Q4 2014. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

WealthTrust Fairport held 28 shares of Teva Pharmaceuticals worth $0 as of Q1 2019.
WealthTrust Fairport left its Teva Pharmaceuticals share count unchanged in Q1 2019.
Teva Pharmaceuticals made up ﹤0.01% of WealthTrust Fairport's portfolio in Q1 2019, its #464 holding.
WealthTrust Fairport first reported a position in Teva Pharmaceuticals in Q3 2013 and has held it in 10 quarters since.
WealthTrust Fairport's Teva Pharmaceuticals position peaked at $2K in Q4 2014.
522 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.